Kent Christopherson

Dr. Christopherson is the Senior Director, Medical Affairs at Orchard Therapeutics, a biotech company dedicated to unlocking the curative potential of hematopoietic stem cell – gene therapy for the benefit of individuals, families, and society. He is an accomplished medical affairs leader with >15 years of relevant clinical and scientific experience as well as multiple successful product launches within rare and ultra-rare diseases.

In his current role, he brings substantial real-world experience from time spent working in academic medical centers and biotech to bear on the ever-evolving therapeutic landscape of gene therapy for the treatment of severe genetic diseases. He specializes in strategy, creation, and development of highly motivated and effective medical affairs teams focused on the value proposition for engagement of multiple external stakeholder types. His principal topics of expertise extend to include the cross-functional role of medical affairs in clinical insights, clinical development, market access, patient advocacy, and public affairs to drive corporate and medical affairs strategy throughout the product life cycle.